Rhodiola Rosea Extract Supplement

No. Rhodiola is an adaptogen, not a stimulant. It doesn’t act on the central nervous system the way caffeine does — there’s no jitter, no spike, no crash. Most users describe the effect as a clearer, steadier baseline rather than a noticeable lift. That makes it well-suited to people who are sensitive to stimulants or who already drink coffee and don’t want to stack another stimulant on top.

Yes, rhodiola is well-tolerated for ongoing daily use at standard doses. The typical clinical range is 200–600 mg per day of a standardized extract — Double Wood is standardized to 3% salidrosides and 1% rosavins, with a suggested dose of one to two 500 mg capsules in the morning. Take it earlier in the day rather than late, since the energy support can be subtly noticeable. Talk to your healthcare provider if you’re pregnant, nursing, or on prescription medications.

They’re both adaptogens but they pull in different directions. Ashwagandha is typically chosen for evening calm and sleep support — its stress effect is more sedative. Rhodiola is typically chosen for daytime use — its stress effect comes with cognitive and physical stamina support rather than relaxation. Many people pair the two: rhodiola in the morning, ashwagandha in the evening.

Some users notice a subtle effect on focus and stamina within the first few days. The full stress-resilience benefit is more typically reported after two to four weeks of consistent daily use, which is in line with most adaptogen research. Rhodiola works best as a daily supplement, not as an as-needed one.

Salidrosides are the compounds most associated with rhodiola’s stress-response and cognitive support effects. A 3% salidrosides extract means the extract is standardized so every capsule delivers a consistent, clinically relevant amount of the active. Many commodity rhodiola products standardize to 1% salidrosides — or don’t standardize at all — which is why response can be inconsistent. Standardization is what makes the daily dose predictable.

Yes. Every batch is third-party tested by an ISO/IEC 17025-accredited laboratory for identity, active compound content, heavy metals, and microbial safety. Rhodiola rosea root extract is standardized to 3% rosavins and 1% salidroside — the same ratio used in the majority of published clinical trials on stress and fatigue. Active compounds (rosavins and salidroside) are quantified by HPLC against reference standards. The full COA panel covers four heavy metals via ICP-MS (arsenic, cadmium, lead, mercury against USP <2232> limits) and six microbial screens (TPC, Yeast & Mold, Coliform, E. coli, Salmonella, Staph aureus per USP and AOAC methods). Manufactured in a cGMP-certified U.S. facility.

The COA verifies 500 mg of Rhodiola rosea root extract per capsule (3% rosavins / 1% salidroside standardization) by HPLC. This delivers approximately 15 mg of rosavins and 5 mg of salidroside per capsule — the active compound levels used in published research on adaptogenic and stress-resilience effects. Identity is verified against the Rhodiola rosea reference profile (distinguishing it from adulterant species like Rhodiola crenulata). Heavy metals: arsenic, cadmium, lead, and mercury verified below USP <2232> daily-intake limits via ICP-MS. Microbials within USP and AOAC specifications. The current batch COA is linked above for verification against the lot number on your bottle.